Publicacións en colaboración con investigadores/as de Hospital de Fuenlabrada (13)

2019

  1. Frequency of clonal mast cell diseases among patients presenting with anaphylaxis: A prospective study in 178 patients from 5 tertiary centers in Spain

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 8, pp. 2924-2926.e1

  2. The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients

    British Journal of Haematology, Vol. 186, Núm. 2, pp. 263-268

2016

  1. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

    Oncotarget, Vol. 7, Núm. 9, pp. 10174-10181

  2. Diagnosis and classification of mastocytosis in non-specialized versus reference centres: A Spanish Network on Mastocytosis (REMA) study on 122 patients

    British Journal of Haematology, Vol. 172, Núm. 1, pp. 56-63

2014

  1. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM

    Journal of Allergy and Clinical Immunology, Vol. 133, Núm. 2

2013

  1. Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis

    Journal of Allergy and Clinical Immunology

2012

  1. Mast cell-related disorders presenting with Kounis syndrome

    International Journal of Cardiology, Vol. 161, Núm. 1, pp. 56-58

  2. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms

    International Archives of Allergy and Immunology, Vol. 157, Núm. 3, pp. 275-280

2011

  1. Evaluation of basophil activation in mastocytosis with hymenoptera venom anaphylaxis

    Cytometry Part B - Clinical Cytometry, Vol. 80 B, Núm. 3, pp. 167-175

  2. Evaluation of the WHO criteria for the classification of patients with mastocytosis

    Modern Pathology, Vol. 24, Núm. 9, pp. 1157-1168

  3. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis

    Immunotherapy, Vol. 3, Núm. 5, pp. 637-651

2010

  1. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

    Journal of Allergy and Clinical Immunology, Vol. 125, Núm. 6

2008

  1. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis

    Journal of Allergy and Clinical Immunology, Vol. 121, Núm. 2, pp. 519-526